These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 597607

  • 1. [Antitumor effect of glycopeptides from the cell wall of Lactobacillus bulgaricus].
    Bogdanov IG, Velichkov VT, Gurevich AI, Dalev PG, Kolosov MN.
    Biull Eksp Biol Med; 1977 Dec; 84(12):709-12. PubMed ID: 597607
    [Abstract] [Full Text] [Related]

  • 2. [Mass-spectrometric determination of the structure of glycopeptides from the bacterial cell wall (illustrated by Lactobacillus bulgaricus)].
    Reshetova OS, Rozynov BV, Bezrukov MV, Bogdanova IA.
    Bioorg Khim; 1986 Dec; 12(12):1625-36. PubMed ID: 3814188
    [Abstract] [Full Text] [Related]

  • 3. [Macrophage activation by blastolysin].
    Sorokina IB, Khasman EL, Gor'kova NP, Uchitel' IIa.
    Biull Eksp Biol Med; 1980 Apr; 89(4):449-52. PubMed ID: 7388160
    [Abstract] [Full Text] [Related]

  • 4. Antitumour glycopeptides from Lactobacillus bulgaricus cell wall.
    Bogdanov IG, Dalev PG, Gurevich AI, Kolosov MN, Malékova VP, Plemyannikova LA, Sorokina IB.
    FEBS Lett; 1975 Oct 01; 57(3):259-61. PubMed ID: 1181198
    [No Abstract] [Full Text] [Related]

  • 5. [Mechanism of the anti-tumoral effect of the blastolysin fraction isolated from Lactobacillus bulgaricus].
    Ketlinskiĭ SA, Prokop'eva ED, Prokop'ev AA, Artiukhov AI, Pasechnik VA.
    Vopr Onkol; 1987 Oct 01; 33(3):51-6. PubMed ID: 3564372
    [Abstract] [Full Text] [Related]

  • 6. [Isolation and structure of the active component of the antitumor agent blastolysin].
    Bezrukov MV, Andronova TM, Reshetova OS, Mal'kova VP, Sorokina IB.
    Bioorg Khim; 1987 Mar 01; 13(3):386-94. PubMed ID: 3593429
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T, Shimomura K, Mukumoto S, Kobayashi K, Mizota T, Hirai O, Matsumoto S, Oku T, Nishigaki F, Mori J.
    Cancer Res; 1987 Jul 15; 47(14):3707-11. PubMed ID: 3594435
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Therapeutic effect of blastolysin in athymic mice with transplanted strains of human tumors].
    Dmitrieva NV, Revazova ES, Garin AM.
    Eksp Onkol; 1988 Jul 15; 10(2):69-71. PubMed ID: 3391126
    [Abstract] [Full Text] [Related]

  • 10. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice.
    Sekine K, Toida T, Saito M, Kuboyama M, Kawashima T, Hashimoto Y.
    Cancer Res; 1985 Mar 15; 45(3):1300-7. PubMed ID: 3971375
    [Abstract] [Full Text] [Related]

  • 11. [Antitumor action of cis-dichlorodiammineplatinum(II) and the effectiveness of a combination with sarcolysine].
    Presnov MA, Konovalova AL, Romanova LF, Sof'ina ZP, Stetsenko AI.
    Vopr Onkol; 1978 Mar 15; 24(4):53-60. PubMed ID: 654174
    [Abstract] [Full Text] [Related]

  • 12. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
    Jia ZP, Wang R, Xie JW, Xu LT.
    Zhongguo Yao Li Xue Bao; 1999 Jun 15; 20(6):571-6. PubMed ID: 10678157
    [Abstract] [Full Text] [Related]

  • 13. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
    Nio Y, Hirahara N, Minari Y, Iguchi C, Yamasawa K, Toga T, Tamura K.
    Anticancer Res; 2000 Jun 15; 20(5A):3293-9. PubMed ID: 11062756
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G.
    Cancer Chemother Pharmacol; 2002 Dec 15; 50(6):490-6. PubMed ID: 12451476
    [Abstract] [Full Text] [Related]

  • 15. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M.
    Cancer Res; 1982 Feb 15; 42(2):440-4. PubMed ID: 7055799
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U, Mett H, Stanek J, Mueller M, Kramer D, Porter CW.
    Cancer Res; 1994 Jun 15; 54(12):3210-7. PubMed ID: 8205541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. I. Acute toxicity and antitumor activity in mouse transplantable tumor systems.
    Matuszyk J, Kuśnierczyk H, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1989 Jun 15; 37(1-2):77-88. PubMed ID: 2619512
    [Abstract] [Full Text] [Related]

  • 20. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB, Ye QW.
    Cancer Res; 1985 Oct 15; 45(10):4932-9. PubMed ID: 4027979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.